Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × NETWORK × lorlatinib × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

INDUSTRY 4 OTHER 3 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 13 Vincristine 12 Magnetic Resonance Spectroscopy 12 Dexamethasone 12 Cisplatin 12 Carboplatin 12 Specimen Handling 11 Radiotherapy 10 Etoposide 10 durvalumab 9 Radiation 9 Paclitaxel 9 Doxorubicin 8 Radiotherapy, Intensity-Modulated 7 Lenalidomide 7 Fluorouracil 7 Docetaxel 7 Cytarabine 7 daratumumab 6 Prednisone 6 Platinum 6 Leucovorin 6 Bortezomib 6 tremelimumab 5 dehydroftorafur 5 Watchful Waiting 5 Temozolomide 5 Taxes 5 Rituximab 5 Radiotherapy, Conformal 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04127110 2024-11-05

ALKALINE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡